Ten scientific reasons in support of airborne transmission of SARS-CoV-2
Covid Lists
Long distance airborne transmission of SARS-CoV-2: rapid systematic review
Airborne transmission of respiratory viruses
The physics of respiratory particle generation, fate in the air, and inhalation
Clean Air Expo
2023 Clean Indoor Air Expo
Long COVID research risks losing momentum – we need a moonshot
Weekly Provisional Counts of Deaths by State and Select Causes, 2020-2023 | Data | Centers for Disease Control and Prevention
Evaluation of science advice during the COVID-19 pandemic in Sweden
Column: Did Sweden beat the pandemic by refusing to lock down? No, its record is disastrous
The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research
Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study
Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in non-human primates
XBB.1.5 Spike Protein COVID-19 Vaccine Induces Broadly Neutralizing and Cellular Immune Responses Against EG.5.1 and Emerging XBB Variants
Protein Vaccine Demonstrates Less Reactogenicity than mRNA – A Real World Study
Notes from the Field: Safety Monitoring of Novavax...
NVX-CoV2373-induced cellular and humoral immunity towards parental SARS-CoV-2 and VOCs compared to BNT162b2 and mRNA-1273-regimens
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial
Comparing reactogenicity of COVID-19 vaccines: a systematic review and meta-analysis
Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial
The Updated COVID Vaccines Are Here: 10 Things to Know
Novavax is here!
Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study
Has covid-19 become milder?
Review estimates 69% 3-dose vaccine efficacy against long COVID | CIDRAP
Quick takes: Novavax COVID vaccine protection, COVID booster uptake, avian flu in 2 states
The Tree That Could Help Stop the Pandemic
The mRNA Vaccines Are Extraordinary, but Novavax Is Even Better
How the Novavax Vaccine Works (Published 2022)
Comparing the COVID-19 Vaccines: How Are They Different?